Inflammatory Bowel Disease and Atherosclerosis Development
Active, not recruiting
- Conditions
- Inflammatory Bowel DiseasesCardiovascular DiseasesInflammationArterial Stiffness
- Registration Number
- NCT05781737
- Brief Summary
- The study will show the influence of inflammatory bowel disease on the risk of development of atherosclerosis 
- Detailed Description
- Not available 
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 115
Inclusion Criteria
- Inflammatory bowel disease
- Signed informed consent
Exclusion Criteria
- Pregnancy
- Other conditions affecting the prognosis
- Psychiatric disorders affecting the participation in the study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
- Name - Time - Method - Intima-media thickness - 1 year - Intima-media thickness - Pulse wave velocity - 1 year - Pulse wave velocity 
- Secondary Outcome Measures
- Name - Time - Method - Hospitalisation due to cardiovascular disease - 1 year - All cause mortality - 1 year - Cardiovascular mortality - 1 year 
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What immune pathways and cytokines (e.g., IL-6, TNF-α) mediate atherosclerosis development in IBD patients per NCT05781737?
How does IBD-related systemic inflammation compare to traditional risk factors in predicting atherosclerosis progression in NCT05781737?
Which inflammatory biomarkers (CRP, Lp-PLA2) predict atherosclerosis risk in IBD cohorts from NCT05781737 observational data?
Do IBD treatments (anti-TNF, JAK inhibitors) correlate with arterial stiffness or cardiovascular events in NCT05781737 participants?
What pharmacological agents targeting both IBD and atherosclerosis (e.g., statins, anti-inflammatory drugs) show synergistic potential based on NCT05781737 findings?
Trial Locations
- Locations (1)
- University Hospital #1 🇷🇺- Moscow, Russian Federation University Hospital #1🇷🇺Moscow, Russian Federation
